Time to lower the price of Xpert cartridges to US$5

Advocates request Cepheid immediately reduce the price of Xpert tests to US$5, inclusive of service and maintenance; the company responds they are “not able to predict the amount of further reductions or when they may be available”; advocates reiterate the request that Cepheid provide a detailed plan for how it will lower the price of Xpert tests to US$5.

Read More →

TB Alliance responds to questions raised by activists in relation to pretomanid

MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.

Read More →

WHO announces changes to the treatment of drug-resistant TB

WHO releases a Rapid Communication in advance of the updated guidelines for the treatment of drug-resistant TB expected in 2020.

Read More →

New TAG report: Funding for TB research climbed to new high in 2018

The report — Tuberculosis Research Funding Trends, 2005–2018 — presents new data on funding for TB research and development in 2018 and analyzes trends in spending since 2005.

Read More →

Stop TB Partnership launches the updated Global Plan to End TB 2018-2022

The updated Global Plan calls for 2.6 billion USD per year for vital research and development of new TB diagnostic tools, new drug regimens and a new vaccine, and 13 billion USD per year for TB care and prevention.

Read More →

Stop TB Partnership launches the Challenge Facility for Civil Society 2019

The largest-ever call for proposals for community and civil society for a TB response that is rights-based, gender-transformative, people-centered and accountable is announced.

Read More →

Stop TB Partnership launches the TB Stigma Assessment Tool

The Tool aims to assess the extent to which and how TB stigma acts as a barrier to accessing services and to support the development of recommendations to address TB stigma so that quality TB services are available, accessible and acceptable to all.

Read More →

TAG applauds Indian TB activists in opposing patents for critical TB prevention drugs

Civil society takes legal action to contest patent applications filed by Sanofi on fixed-dose combinations of two decades-old drugs used to prevent TB.

Read More →

Interactive TB mapping tool

The Stop TB Partnership interactive mapping TB tool is now LIVE.

Read More →

ATS, CDC, ERS and IDSA publish new clinical guideline for the treatment and prevention of drug-resistant TB

New guideline emphasizes treatment of drug-resistant TB with all-oral regimens and provides recommendations for treatment of all contacts to multidrug-resistant TB patients.

Read More →

Page 2 of 103 · Total posts: 10

←First 1 2 3 Last→